Filing Details

Accession Number:
0001179110-17-011479
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-14 20:00:33
Reporting Period:
2017-08-11
Filing Date:
2017-08-14
Accepted Time:
2017-08-14 20:00:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1583107 Theravance Biopharma Inc. TBPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1233438 M George Whitesides C/O Theravance Biopharma Us, Inc.
901 Gateway Boulevard
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2017-08-11 4,000 $24.69 4,000 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 184,392 Direct
Ordinary Shares 48,662 Indirect By Family Trust